TPX2 and nonpapillary renal cell carcinoma: TPX2, a regulator of Aurora-A, was established as correlated with advanced ccRCC grade and stage and identified as an independent predictor of recurrence in a tissue microarray comprising 207 patients (Glaser et al., 2017).